Jeroen B. van Beek - 20 Apr 2022 Form 4 Insider Report for Allovir, Inc. (KLRS)

Role
Chief Commercial Officer
Signature
/s/ Brett Hagen, as Attorney-in-Fact
Issuer symbol
KLRS
Transactions as of
20 Apr 2022
Net transactions value
-$5,695
Form type
4
Filing time
22 Apr 2022, 08:28:39 UTC
Previous filing
03 Mar 2022
Next filing
18 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALVR Common Stock Sale $5,695 -852 -0.21% $6.68 404,788 20 Apr 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units, and does not represent a discretionary trade by the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $6.665 to $6.6976. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.